ACT
Price
$48.15
Change
+$0.97 (+2.06%)
Updated
Nov 2 closing price
Capitalization
6.62B
2 days until earnings call
Intraday BUY SELL Signals
RDN
Price
$36.18
Change
+$0.64 (+1.80%)
Updated
Nov 2, 04:59 PM (EDT)
Capitalization
4.7B
2 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACT vs RDN

ACT vs RDN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACT vs. RDN commentary
Nov 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACT is a StrongBuy and RDN is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ACT with price predictions
Oct 30, 2026

Momentum Indicator for ACT turns positive, indicating new upward trend

ACT saw its Momentum Indicator move above the 0 level on October 22, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned positive. In 57 of the 90 cases, the stock moved higher in the following days. The odds of a move higher are at 63%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ACT's RSI Indicator exited the oversold zone, 11 of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 52%.

The Moving Average Convergence Divergence (MACD) for ACT just turned positive on October 15, 2026. Looking at past instances where ACT's MACD turned positive, the stock continued to rise in 27 of 45 cases over the following month. The odds of a continued upward trend are 60%.

Following a +2.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACT advanced for three days, in 215 of 353 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

The Aroon Indicator entered an Uptrend today. In 119 of 237 cases where ACT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 50%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

ACT moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ACT crossed bearishly below the 50-day moving average on September 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 35%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.

ACT broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. ACT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.227) is normal, around the industry mean (0.992). P/E Ratio (10.094) is within average values for comparable stocks, (11.162). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.944). Dividend Yield (0.020) settles around the average of (0.502) among similar stocks. ACT's P/S Ratio (5.627) is slightly higher than the industry average of (2.529).

A.I.Advisor
a Summary for RDN with price predictions
Oct 30, 2026

RDN's RSI Indicator recovers from oversold territory

The RSI Oscillator for RDN moved out of oversold territory on October 02, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 21 similar instances when the indicator left oversold territory. In 16 of the 21 cases the stock moved higher. This puts the odds of a move higher at 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on RDN as a result. In 52 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.

The Moving Average Convergence Divergence (MACD) for RDN just turned positive on October 06, 2026. Looking at past instances where RDN's MACD turned positive, the stock continued to rise in 31 of 50 cases over the following month. The odds of a continued upward trend are 62%.

RDN moved above its 50-day moving average on October 23, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RDN crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 24 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 58%.

Following a +5.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDN advanced for three days, in 194 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

The Aroon Indicator entered an Uptrend today. In 143 of 260 cases where RDN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 62 cases where RDN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 61%.

The 50-day moving average for RDN moved below the 200-day moving average on October 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

RDN broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 23 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. RDN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.978) is normal, around the industry mean (0.992). P/E Ratio (9.090) is within average values for comparable stocks, (11.162). Projected Growth (PEG Ratio) (0.230) is also within normal values, averaging (0.944). Dividend Yield (0.029) settles around the average of (0.502) among similar stocks. P/S Ratio (2.960) is also within normal values, averaging (2.529).

The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
ACT vs RDN: Fundamental Ratings
ACT
RDN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
323
SMR RATING
1..100
8088
PRICE GROWTH RATING
1..100
4246
P/E GROWTH RATING
1..100
2137
SEASONALITY SCORE
1..100
3050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RDN's Valuation (71) in the Specialty Insurance industry is in the same range as ACT (88) in the null industry. This means that RDN’s stock grew similarly to ACT’s over the last 12 months.

ACT's Profit vs Risk Rating (3) in the null industry is in the same range as RDN (23) in the Specialty Insurance industry. This means that ACT’s stock grew similarly to RDN’s over the last 12 months.

ACT's SMR Rating (80) in the null industry is in the same range as RDN (88) in the Specialty Insurance industry. This means that ACT’s stock grew similarly to RDN’s over the last 12 months.

ACT's Price Growth Rating (42) in the null industry is in the same range as RDN (46) in the Specialty Insurance industry. This means that ACT’s stock grew similarly to RDN’s over the last 12 months.

ACT's P/E Growth Rating (21) in the null industry is in the same range as RDN (37) in the Specialty Insurance industry. This means that ACT’s stock grew similarly to RDN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACTRDN
RSI
ODDS (%)
Bullish Trend 4 days ago
52%
Bullish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
53%
Bearish Trend 4 days ago
61%
Momentum
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
63%
MACD
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
49%
Bearish Trend 4 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
54%
Bullish Trend 4 days ago
55%
Advances
ODDS (%)
Bullish Trend 8 days ago
61%
Bullish Trend 11 days ago
58%
Declines
ODDS (%)
Bearish Trend 6 days ago
52%
Bearish Trend 6 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
58%
Bearish Trend 4 days ago
63%
Aroon
ODDS (%)
Bullish Trend 4 days ago
50%
Bullish Trend 4 days ago
55%
COMPARISON
Comparison
Nov 03, 2026
Stock price -- (ACT: $47.18 vs. RDN: $35.54)
Brand notoriety: ACT and RDN are both not notable
Both companies represent the Specialty Insurance industry
Current volume relative to the 65-day Moving Average: ACT: 92% vs. RDN: 63%
Market capitalization -- ACT: $6.62B vs. RDN: $4.7B
ACT [@Specialty Insurance] is valued at $6.62B. RDN’s [@Specialty Insurance] market capitalization is $4.7B. The market cap for tickers in the [@Specialty Insurance] industry ranges from $2.22M to $10.86B. The average market capitalization across the [@Specialty Insurance] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACT’s FA Score shows that 2 FA rating(s) are green while RDN’s FA Score has 1 green FA rating(s).

  • ACT’s FA Score: 2 green, 3 red.
  • RDN’s FA Score: 1 green, 4 red.
According to our system of comparison, both ACT and RDN are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACT’s TA Score shows that 5 TA indicator(s) are bullish while RDN’s TA Score has 7 bullish TA indicator(s).

  • ACT’s TA Score: 5 bullish, 5 bearish.
  • RDN’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, RDN is a better buy in the short-term than ACT.

Price Growth

ACT (@Specialty Insurance) experienced а -1.48% price change this week, while RDN (@Specialty Insurance) price change was -0.59% for the same time period.

The average weekly price growth across all stocks in the @Specialty Insurance industry was -0.16%. For the same industry, the average monthly price growth was +5.79%, and the average quarterly price growth was +1.09%.

Reported Earning Dates

ACT is expected to report earnings on Nov 04, 2026.

RDN is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Specialty Insurance (-0.16% weekly)

Specialty insurance typically caters to niche-markets, and covers items that are special or unique and/or items that are not typically covered under other insurance policies. Restoration or purchase of a one-of-a-kind collector’s item, high-value home, recreational vehicles, sailboat or even jet skis, horses and farms, all-terrain vehicle, funerals, museums and fine art collections are some examples– one or more of which are covered by a specialty insurance provider. In some cases, a specialty insurance could also complement someone’s existing auto, home and umbrella policies. Markel Corp, for Fidelity National Financial, Inc., Assurant, Inc. and Athene Holding Ltd. are examples of specialty insurance providers.

View a ticker or compare two or three
ACT
Daily Signal:
Gain/Loss:
RDN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ACT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACT has been closely correlated with NMIH. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACT jumps, then NMIH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACT
1D Price
Change %
ACT100%
-1.83%
NMIH - ACT
80%
Closely correlated
-1.18%
ESNT - ACT
79%
Closely correlated
-0.86%
MTG - ACT
77%
Closely correlated
-1.53%
RDN - ACT
67%
Closely correlated
-0.39%
AIZ - ACT
58%
Loosely correlated
+0.04%
More

RDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, RDN has been closely correlated with ESNT. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if RDN jumps, then ESNT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDN
1D Price
Change %
RDN100%
-0.39%
ESNT - RDN
76%
Closely correlated
-0.86%
MTG - RDN
74%
Closely correlated
-1.53%
ACT - RDN
67%
Closely correlated
-1.83%
AIZ - RDN
56%
Loosely correlated
+0.04%
AXS - RDN
39%
Loosely correlated
+1.97%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FVD50.710.18
+0.36%
First Trust Value Line Dividend Index Fund (FVD)
XCOR88.08N/A
N/A
FundX ETF (XCOR)
PMJN27.00-0.10
-0.38%
PGIM S&P 500 Max Buffer ETF - June (PMJN)
BRES25.40-0.46
-1.76%
Burney U.S. Equity Select ETF (BRES)
EMC33.57-0.88
-2.56%
Global X Emerging Markets Great Consumer ETF (EMC)